PATENT CLAIM ANALYSIS

Application Number: 16071687
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["546", "087000"]

Abstract:
A compound of general formula A, useful as potential anticancer agents against human cancer cell lines and process for the preparation thereof. General formula A R 1 =3-F, 3,4,5-OMe, 4-OMe, H, 4-CF 3 , 4-Cl, 4-OH-3-OMe, 3,4-CH 2 —O—CH 2 , 3,5-F, 4-OH, 1-napthyl, 9-phenanthryl, 4-Me. R 2 =3,4,5-OMe, 3,4-Cl, 4-F, 3,5-F, 2,5-OMe, 4-Cl, 4-OH-3-OMe, 3-OH, 3,4,5-OH, 4-CF 3 , 4-OMe, 4-NH 2

Claim (Index 6):
The process as claimed in  claim 5 , wherein the compound of formula 22a-l is selected from the group consisting of

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.7551
- Patent Class: 546.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15504985', '14689742', '13502944', '10326081', '13509442']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8718884544842704
- 35 USC 102 Novelty (BERT): 0.5426715316373223
- Combined Prediction Score: 0.8389667621995757
- Mean Citation Score: 418.263468
- Max Citation Score: 466.71274000000005
- Similarity Product: 261.47622251468897

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test